ESTUTC-5 New YorkLog in Sign up

AVTX
Avalo Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:58 PM EST

7.75USD+0.649%(+0.05)974,091

Pre-marketNov 13, 2026 8:34:30 AM EST

7.75USD+0.649%(+0.05)

After-hoursNov 13, 2026 4:00:30 PM EST

7.76USD+0.129%(+0.01)

AVTX News

Day breaks

07:57 PM ESTFMR LLC Trims Avalo Therapeutics Inc (AVTX) Stake -- Shares Look 2,006% Overvalued on GF Value ·

GuruFocus

02:40 PM ESTAvalo Therapeutics at Stifel 2026 Healthcare Conference: phase iii ahead ·

Investing.com

12:36 PM ESTAVTX Maintained by Wedbush -- Price Target Lowered to $20.00 ·

GuruFocus

01:12 AM ESTStifel cuts Avalo Therapeutics stock price target on trial data ·

Investing.com

07:43 AM ESTAvalo Therapeutics GAAP EPS of -$0.34 beats by $0.27 ·

Seeking Alpha

04:00 PM ESTAvalo Therapeutics to Participate in Upcoming Investor Conferences ·

GlobeNewswire Inc.

04:01 AM ESTAvalo Therapeutics CFO Sullivan sells $202,437 in stock ·

Investing.com

02:44 PM EDTOppenheimer cuts Avalo Therapeutics price target on trial concerns ·

Investing.com

06:54 AM EDTGuggenheim downgrades Avalo Therapeutics stock rating on IL-1 data ·

Investing.com

08:50 AM EDTH.C. Wainwright reiterates Avalo Therapeutics stock rating at buy ·

Investing.com

04:01 PM EDTAvalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) ·

GlobeNewswire Inc.

03:19 PM EDTNoteworthy Friday Option Activity: OFG, AVTX, VST ·

BNK Invest

10:09 AM EDTAvalo Therapeutics at Stifel forum: hs push gains traction ·

Investing.com

07:00 AM EDTAvalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress ·

GlobeNewswire Inc.

08:54 AM EDTAvalo Therapeutics at H.C. Wainwright conference: phase 2 data lift outlook ·

Investing.com

08:26 AM EDTCantor Fitzgerald reiterates Avalo Therapeutics stock rating ·

Investing.com